Tempus AI buys Personalis for $1.5 billion

Updated at: July 21, 2026 at 02:00 AM

On July 20, 2026, the Chicago-based healthcare technology leader Tempus AI announced a significant move to acquire Personalis, Inc., a prominent cancer-testing company.

noun2026

nounTempus AI

verbannounce

nounPersonalis, Inc.

nouncancer

Valued at $1.5 billion, this strategic acquisition aims to strengthen Tempus AI’s position in the precision oncology market.

nounTempus AI

nounoncology

By integrating Personalis’s NeXT Personal MRD technology, Tempus plans to leverage its vast commercial reach—covering over 50% of U.S. oncologists—to improve the detection and treatment monitoring of cancer recurrence.

nouncancer

While the deal represents a substantial investment in innovation, the market reaction was initially cautious, with shares of both companies seeing a decline following the announcement.

nouninvestment

adjectivecautious

Investors are closely watching the integration process and regulatory hurdles, as the acquisition is expected to finalize between late 2026 and early 2027.

noun2026

This merger marks a major step forward in using artificial intelligence and genetic testing to provide more personalized and effective care for cancer patients across the country.

nounartificial intelligence

nouncancer

nounpatient

🎉

End of article

You read 6 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary focus of the acquisition between Tempus AI and Personalis?

Advancing precision oncology through minimal residual disease (MRD) testing.

Developing new surgical robotics for hospitals.

Expanding into international pharmaceutical manufacturing.

Reveal Answer

✓

Correct Choice

Advancing precision oncology through minimal residual disease (MRD) testing.

What is the total value of the transaction?

$1.5 billion.

$1.7 billion.

$500 million.

Reveal Answer

✓

Correct Choice

$1.5 billion.

When is the acquisition expected to close?

By the end of 2025.

Late 2026 or early 2027.

Within the current fiscal quarter.

Reveal Answer

✓

Correct Choice

Late 2026 or early 2027.

How did the market react to the announcement?

Both companies saw a significant surge in their stock prices.

Investors reacted with caution, causing shares of both companies to decline.

Investors were largely indifferent, with no change in share value.

Reveal Answer

✓

Correct Choice

Investors reacted with caution, causing shares of both companies to decline.

What is one strategic advantage for Tempus AI in this merger?

Eliminating all competition in the healthcare technology sector.

Gaining ownership of Personalis's existing real estate portfolio.

Using its commercial infrastructure to reach over 50% of U.S. oncologists.

Reveal Answer

✓

Correct Choice

Using its commercial infrastructure to reach over 50% of U.S. oncologists.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play